Chordate Medical Holding AB Logo

Chordate Medical Holding AB

Develops drug-free neuromodulation tech for chronic migraine & rhinitis in the EU & Middle East.

CMH | ST

Overview

Corporate Details

ISIN(s):
SE0021486131 (+1 more)
LEI:
549300R0GG2J3S0BFN79
Country:
Sweden
Address:
C/O Regus, 164 40 Kista
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

Chordate Medical Holding AB is a medical technology company that has developed, patented, and CE-marked Ozilia®, a drug-free neuromodulation treatment technology. The product is designed for the treatment of chronic migraine and chronic rhinitis, offering a clinically proven alternative to conventional medication with minimal side effects. The company markets its treatment in selected markets within the EU and the Middle East. Its business strategy is focused on building value through clinical validation, an extensive patent portfolio, and commercial success stories to attract prospective buyers for a future exit.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chordate Medical Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Tommy Hedberg Other Other 2,917 11,668.00 SEK
2024-03-26 Anders Weilandt Other Buy 800,000 41,440.00 SEK
2024-03-26 Anders Weilandt Other Buy 200,000 10,540.00 SEK
2023-05-26 Anders Weilandt Other Buy 2,000,000 84,000.00 SEK
2023-05-26 Jan Hermansson Other Buy 750,000 31,500.00 SEK
2023-05-26 Nils Henrik Milton Rammer Other Other 350,000 14,700.00 SEK
2023-05-26 Caroline Brandberg Other Other 225,000 9,450.00 SEK
2023-05-26 Tommy Hedberg Other Buy 225,000 9,450.00 SEK
2023-01-09 Anders Weilandt Other Buy 3 2.10 SEK
2022-02-25 Anders Weilandt Other Buy 51,292 3,949,484.00 SEK

Peer Companies

Predict S.p.A. Logo
Distributes diagnostic imaging systems and develops proprietary digital health platforms.
Italy
PRE
Profound Medical Corp. Logo
Develops incision-free, MRI-guided ultrasound therapy for ablating prostate tissue.
United States of America
PROF
P&S Robotics Co., Ltd. Logo
Develops and manufactures exoskeleton robots for medical gait rehabilitation worldwide.
South Korea
460940
Pulsenmore Ltd. Logo
Enables remote prenatal care via a home ultrasound device for self-scans by expectant mothers.
Israel
PULS
Pulsion Medical Systems SE Logo
Develops advanced, minimally invasive monitoring systems for critically ill patients.
Germany
PUS
Q-Linea Logo
Develops rapid, automated antimicrobial susceptibility testing for critical infections.
Sweden
QLINEA
Ray Co., Ltd. Logo
Provides integrated digital dentistry solutions: imaging scanners, CAD software, and 3D printers.
South Korea
228670
RAYENCE CO.,LTD. Logo
Manufactures digital X-ray detectors & systems for medical, dental, vet, and industrial markets.
South Korea
228850
REMED CO.,LTD. Logo
Develops & manufactures non-invasive neural modulation devices for rehab & brain disease treatment.
South Korea
302550
ScanTech AI Systems Inc. Logo
AI-powered CT screening for threat detection in aviation, defense, and logistics.
United States of America
STAI

Talk to a Data Expert

Have a question? We'll get back to you promptly.